GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia
Publication date: Available online 5 April 2021Source: Clinica Chimica ActaAuthor(s): Wenyu Wang, Zhuoru He, Yu Kong, Zhongqiu Liu, Lingzhi Gong
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Laboratory Medicine | Prostate Cancer